Jak1	B:C0169658
-	O
STAT3	O
Signals	O
Are	O
Essential	O
Effectors	O
of	O
the	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
/	O
TRE17	O
Oncogene	I:C1175888
in	O
Tumorigenesis	O
.	O

Jak1	O
-	O
STAT3	B:C0253050
Signals	O
Are	O
Essential	O
Effectors	O
of	O
the	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
/	O
TRE17	O
Oncogene	I:C1175888
in	O
Tumorigenesis	O
.	O

Jak1	O
-	O
STAT3	O
Signals	B:C0037083
Are	O
Essential	O
Effectors	O
of	O
the	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
/	O
TRE17	O
Oncogene	I:C1175888
in	O
Tumorigenesis	O
.	O

Jak1	O
-	O
STAT3	O
Signals	O
Are	O
Essential	O
Effectors	O
of	O
the	O
ubiquitin	B:C1175888
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
/	O
TRE17	O
Oncogene	I:C1175888
in	O
Tumorigenesis	O
.	O

Jak1	O
-	O
STAT3	O
Signals	O
Are	O
Essential	O
Effectors	O
of	O
the	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
/	O
TRE17	B:C1175888
Oncogene	I:C1175888
in	O
Tumorigenesis	O
.	O

Jak1	O
-	O
STAT3	O
Signals	O
Are	O
Essential	O
Effectors	O
of	O
the	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
/	O
TRE17	O
Oncogene	I:C1175888
in	O
Tumorigenesis	B:C0596263
.	O

Bone	B:C0005967
and	O
soft	O
tissue	I:C0037579
tumors	I:C0037579
(	O
Bone	O
and	I:C0027651
soft	I:C0027651
tissue	I:C0027651
tumors	I:C0027651
)	O
are	O
relatively	O
poorly	O
understood	O
,	O
hampering	O
the	O
development	O
of	O
effective	O
therapies	O
.	O

Bone	O
and	O
soft	B:C0037579
tissue	I:C0037579
tumors	I:C0037579
(	O
Bone	O
and	I:C0027651
soft	I:C0027651
tissue	I:C0027651
tumors	I:C0027651
)	O
are	O
relatively	O
poorly	O
understood	O
,	O
hampering	O
the	O
development	O
of	O
effective	O
therapies	O
.	O

Bone	O
and	O
soft	O
tissue	I:C0037579
tumors	I:C0037579
(	O
Bone	B:C0027651
and	I:C0027651
soft	I:C0027651
tissue	I:C0027651
tumors	I:C0027651
)	O
are	O
relatively	O
poorly	O
understood	O
,	O
hampering	O
the	O
development	O
of	O
effective	O
therapies	O
.	O

Bone	O
and	O
soft	O
tissue	I:C0037579
tumors	I:C0037579
(	O
Bone	O
and	I:C0027651
soft	I:C0027651
tissue	I:C0027651
tumors	I:C0027651
)	O
are	O
relatively	O
poorly	O
understood	O
,	O
hampering	O
the	O
development	O
of	O
effective	O
therapies	B:C0087111
.	O

Here	O
we	O
report	B:C0684224
a	O
role	O
for	O
the	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
(	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
)	O
/	O
TRE17	O
oncogene	I:C1175888
,	O
which	O
is	O
overexpressed	O
upon	O
chromosome	O
translocation	I:C0040715
in	O
various	O
human	O
tumors	O
,	O
including	O
aneurysmal	O
bone	I:C0152244
cyst	I:C0152244
(	O
aneurysmal	O
bone	I:C0152244
cyst	I:C0152244
)	O
,	O
and	O
the	O
related	O
benign	O
lesion	O
nodular	O
fasciitis	I:C0410005
.	O

Here	O
we	O
report	O
a	O
role	O
for	O
the	O
ubiquitin	B:C1175888
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
(	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
)	O
/	O
TRE17	O
oncogene	I:C1175888
,	O
which	O
is	O
overexpressed	O
upon	O
chromosome	O
translocation	I:C0040715
in	O
various	O
human	O
tumors	O
,	O
including	O
aneurysmal	O
bone	I:C0152244
cyst	I:C0152244
(	O
aneurysmal	O
bone	I:C0152244
cyst	I:C0152244
)	O
,	O
and	O
the	O
related	O
benign	O
lesion	O
nodular	O
fasciitis	I:C0410005
.	O

Here	O
we	O
report	O
a	O
role	O
for	O
the	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
(	O
ubiquitin	B:C1175888
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
)	O
/	O
TRE17	O
oncogene	I:C1175888
,	O
which	O
is	O
overexpressed	O
upon	O
chromosome	O
translocation	I:C0040715
in	O
various	O
human	O
tumors	O
,	O
including	O
aneurysmal	O
bone	I:C0152244
cyst	I:C0152244
(	O
aneurysmal	O
bone	I:C0152244
cyst	I:C0152244
)	O
,	O
and	O
the	O
related	O
benign	O
lesion	O
nodular	O
fasciitis	I:C0410005
.	O

Here	O
we	O
report	O
a	O
role	O
for	O
the	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
(	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
)	O
/	O
TRE17	B:C1175888
oncogene	I:C1175888
,	O
which	O
is	O
overexpressed	O
upon	O
chromosome	O
translocation	I:C0040715
in	O
various	O
human	O
tumors	O
,	O
including	O
aneurysmal	O
bone	I:C0152244
cyst	I:C0152244
(	O
aneurysmal	O
bone	I:C0152244
cyst	I:C0152244
)	O
,	O
and	O
the	O
related	O
benign	O
lesion	O
nodular	O
fasciitis	I:C0410005
.	O

Here	O
we	O
report	O
a	O
role	O
for	O
the	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
(	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
)	O
/	O
TRE17	O
oncogene	I:C1175888
,	O
which	O
is	O
overexpressed	B:C1514559
upon	O
chromosome	O
translocation	I:C0040715
in	O
various	O
human	O
tumors	O
,	O
including	O
aneurysmal	O
bone	I:C0152244
cyst	I:C0152244
(	O
aneurysmal	O
bone	I:C0152244
cyst	I:C0152244
)	O
,	O
and	O
the	O
related	O
benign	O
lesion	O
nodular	O
fasciitis	I:C0410005
.	O

Here	O
we	O
report	O
a	O
role	O
for	O
the	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
(	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
)	O
/	O
TRE17	O
oncogene	I:C1175888
,	O
which	O
is	O
overexpressed	O
upon	O
chromosome	B:C0040715
translocation	I:C0040715
in	O
various	O
human	O
tumors	O
,	O
including	O
aneurysmal	O
bone	I:C0152244
cyst	I:C0152244
(	O
aneurysmal	O
bone	I:C0152244
cyst	I:C0152244
)	O
,	O
and	O
the	O
related	O
benign	O
lesion	O
nodular	O
fasciitis	I:C0410005
.	O

Here	O
we	O
report	O
a	O
role	O
for	O
the	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
(	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
)	O
/	O
TRE17	O
oncogene	I:C1175888
,	O
which	O
is	O
overexpressed	O
upon	O
chromosome	O
translocation	I:C0040715
in	O
various	O
human	B:C0086418
tumors	O
,	O
including	O
aneurysmal	O
bone	I:C0152244
cyst	I:C0152244
(	O
aneurysmal	O
bone	I:C0152244
cyst	I:C0152244
)	O
,	O
and	O
the	O
related	O
benign	O
lesion	O
nodular	O
fasciitis	I:C0410005
.	O

Here	O
we	O
report	O
a	O
role	O
for	O
the	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
(	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
)	O
/	O
TRE17	O
oncogene	I:C1175888
,	O
which	O
is	O
overexpressed	O
upon	O
chromosome	O
translocation	I:C0040715
in	O
various	O
human	O
tumors	B:C0027651
,	O
including	O
aneurysmal	O
bone	I:C0152244
cyst	I:C0152244
(	O
aneurysmal	O
bone	I:C0152244
cyst	I:C0152244
)	O
,	O
and	O
the	O
related	O
benign	O
lesion	O
nodular	O
fasciitis	I:C0410005
.	O

Here	O
we	O
report	O
a	O
role	O
for	O
the	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
(	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
)	O
/	O
TRE17	O
oncogene	I:C1175888
,	O
which	O
is	O
overexpressed	O
upon	O
chromosome	O
translocation	I:C0040715
in	O
various	O
human	O
tumors	O
,	O
including	O
aneurysmal	B:C0152244
bone	I:C0152244
cyst	I:C0152244
(	O
aneurysmal	O
bone	I:C0152244
cyst	I:C0152244
)	O
,	O
and	O
the	O
related	O
benign	O
lesion	O
nodular	O
fasciitis	I:C0410005
.	O

Here	O
we	O
report	O
a	O
role	O
for	O
the	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
(	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
)	O
/	O
TRE17	O
oncogene	I:C1175888
,	O
which	O
is	O
overexpressed	O
upon	O
chromosome	O
translocation	I:C0040715
in	O
various	O
human	O
tumors	O
,	O
including	O
aneurysmal	O
bone	I:C0152244
cyst	I:C0152244
(	O
aneurysmal	B:C0152244
bone	I:C0152244
cyst	I:C0152244
)	O
,	O
and	O
the	O
related	O
benign	O
lesion	O
nodular	O
fasciitis	I:C0410005
.	O

Here	O
we	O
report	O
a	O
role	O
for	O
the	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
(	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
)	O
/	O
TRE17	O
oncogene	I:C1175888
,	O
which	O
is	O
overexpressed	O
upon	O
chromosome	O
translocation	I:C0040715
in	O
various	O
human	O
tumors	O
,	O
including	O
aneurysmal	O
bone	I:C0152244
cyst	I:C0152244
(	O
aneurysmal	O
bone	I:C0152244
cyst	I:C0152244
)	O
,	O
and	O
the	O
related	O
benign	O
lesion	B:C0221198
nodular	O
fasciitis	I:C0410005
.	O

Here	O
we	O
report	O
a	O
role	O
for	O
the	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
(	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
)	O
/	O
TRE17	O
oncogene	I:C1175888
,	O
which	O
is	O
overexpressed	O
upon	O
chromosome	O
translocation	I:C0040715
in	O
various	O
human	O
tumors	O
,	O
including	O
aneurysmal	O
bone	I:C0152244
cyst	I:C0152244
(	O
aneurysmal	O
bone	I:C0152244
cyst	I:C0152244
)	O
,	O
and	O
the	O
related	O
benign	O
lesion	O
nodular	B:C0410005
fasciitis	I:C0410005
.	O

Ectopic	B:C1512167
expression	I:C1512167
of	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
is	O
known	O
to	O
drive	O
formation	O
of	O
tumors	O
,	O
which	O
recapitulate	O
key	O
features	O
of	O
aneurysmal	O
bone	I:C0152244
cyst	I:C0152244
and	O
nodular	O
fasciitis	I:C0410005
;	O
however	O
,	O
the	O
identity	O
of	O
USP6's	O
relevant	O
substrates	O
has	O
been	O
obscure	O
.	O

Ectopic	O
expression	I:C1512167
of	O
ubiquitin	B:C1175888
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
is	O
known	O
to	O
drive	O
formation	O
of	O
tumors	O
,	O
which	O
recapitulate	O
key	O
features	O
of	O
aneurysmal	O
bone	I:C0152244
cyst	I:C0152244
and	O
nodular	O
fasciitis	I:C0410005
;	O
however	O
,	O
the	O
identity	O
of	O
USP6's	O
relevant	O
substrates	O
has	O
been	O
obscure	O
.	O

Ectopic	O
expression	I:C1512167
of	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
is	O
known	O
to	O
drive	O
formation	O
of	O
tumors	B:C0027651
,	O
which	O
recapitulate	O
key	O
features	O
of	O
aneurysmal	O
bone	I:C0152244
cyst	I:C0152244
and	O
nodular	O
fasciitis	I:C0410005
;	O
however	O
,	O
the	O
identity	O
of	O
USP6's	O
relevant	O
substrates	O
has	O
been	O
obscure	O
.	O

Ectopic	O
expression	I:C1512167
of	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
is	O
known	O
to	O
drive	O
formation	O
of	O
tumors	O
,	O
which	O
recapitulate	O
key	O
features	O
of	O
aneurysmal	B:C0152244
bone	I:C0152244
cyst	I:C0152244
and	O
nodular	O
fasciitis	I:C0410005
;	O
however	O
,	O
the	O
identity	O
of	O
USP6's	O
relevant	O
substrates	O
has	O
been	O
obscure	O
.	O

Ectopic	O
expression	I:C1512167
of	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
is	O
known	O
to	O
drive	O
formation	O
of	O
tumors	O
,	O
which	O
recapitulate	O
key	O
features	O
of	O
aneurysmal	O
bone	I:C0152244
cyst	I:C0152244
and	O
nodular	B:C0410005
fasciitis	I:C0410005
;	O
however	O
,	O
the	O
identity	O
of	O
USP6's	O
relevant	O
substrates	O
has	O
been	O
obscure	O
.	O

Ectopic	O
expression	I:C1512167
of	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
is	O
known	O
to	O
drive	O
formation	O
of	O
tumors	O
,	O
which	O
recapitulate	O
key	O
features	O
of	O
aneurysmal	O
bone	I:C0152244
cyst	I:C0152244
and	O
nodular	O
fasciitis	I:C0410005
;	O
however	O
,	O
the	O
identity	O
of	O
USP6's	B:C1175888
relevant	O
substrates	O
has	O
been	O
obscure	O
.	O

Here	O
we	O
report	B:C0684224
that	O
the	O
Jak1	O
-	O
STAT3	O
signaling	O
pathway	I:C0037080
serves	O
as	O
an	O
essential	O
effector	O
of	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
in	O
Bone	O
and	I:C0027651
soft	I:C0027651
tissue	I:C0027651
tumors	I:C0027651
formation	O
.	O

Here	O
we	O
report	O
that	O
the	O
Jak1	B:C0169658
-	O
STAT3	O
signaling	O
pathway	I:C0037080
serves	O
as	O
an	O
essential	O
effector	O
of	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
in	O
Bone	O
and	I:C0027651
soft	I:C0027651
tissue	I:C0027651
tumors	I:C0027651
formation	O
.	O

Here	O
we	O
report	O
that	O
the	O
Jak1	O
-	O
STAT3	B:C0253050
signaling	O
pathway	I:C0037080
serves	O
as	O
an	O
essential	O
effector	O
of	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
in	O
Bone	O
and	I:C0027651
soft	I:C0027651
tissue	I:C0027651
tumors	I:C0027651
formation	O
.	O

Here	O
we	O
report	O
that	O
the	O
Jak1	O
-	O
STAT3	O
signaling	B:C0037080
pathway	I:C0037080
serves	O
as	O
an	O
essential	O
effector	O
of	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
in	O
Bone	O
and	I:C0027651
soft	I:C0027651
tissue	I:C0027651
tumors	I:C0027651
formation	O
.	O

Here	O
we	O
report	O
that	O
the	O
Jak1	O
-	O
STAT3	O
signaling	O
pathway	I:C0037080
serves	O
as	O
an	O
essential	O
effector	O
of	O
ubiquitin	B:C1175888
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
in	O
Bone	O
and	I:C0027651
soft	I:C0027651
tissue	I:C0027651
tumors	I:C0027651
formation	O
.	O

Here	O
we	O
report	O
that	O
the	O
Jak1	O
-	O
STAT3	O
signaling	O
pathway	I:C0037080
serves	O
as	O
an	O
essential	O
effector	O
of	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
in	O
Bone	B:C0027651
and	I:C0027651
soft	I:C0027651
tissue	I:C0027651
tumors	I:C0027651
formation	O
.	O

We	O
found	O
that	O
ubiquitin	B:C1175888
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
directly	O
deubiquitinated	O
Jak1	O
,	O
leading	O
to	O
its	O
stabilization	O
and	O
activation	O
of	O
STAT3	O
.	O

We	O
found	O
that	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
directly	O
deubiquitinated	B:C1157996
Jak1	O
,	O
leading	O
to	O
its	O
stabilization	O
and	O
activation	O
of	O
STAT3	O
.	O

We	O
found	O
that	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
directly	O
deubiquitinated	O
Jak1	B:C0169658
,	O
leading	O
to	O
its	O
stabilization	O
and	O
activation	O
of	O
STAT3	O
.	O

We	O
found	O
that	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
directly	O
deubiquitinated	O
Jak1	O
,	O
leading	O
to	O
its	O
stabilization	B:C0184512
and	O
activation	O
of	O
STAT3	O
.	O

We	O
found	O
that	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
directly	O
deubiquitinated	O
Jak1	O
,	O
leading	O
to	O
its	O
stabilization	O
and	O
activation	O
of	O
STAT3	B:C0253050
.	O

The	O
tumorigenic	B:C0007621
potential	O
of	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
was	O
attenuated	O
significantly	O
by	O
CRISPR	O
-	O
mediated	O
deletion	O
of	O
Jak1	O
or	O
STAT3	O
,	O
or	O
by	O
administration	O
of	O
a	O
Jak	O
family	I:C0597721
inhibitor	O
.	O

The	O
tumorigenic	O
potential	O
of	O
ubiquitin	B:C1175888
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
was	O
attenuated	O
significantly	O
by	O
CRISPR	O
-	O
mediated	O
deletion	O
of	O
Jak1	O
or	O
STAT3	O
,	O
or	O
by	O
administration	O
of	O
a	O
Jak	O
family	I:C0597721
inhibitor	O
.	O

The	O
tumorigenic	O
potential	O
of	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
was	O
attenuated	O
significantly	O
by	O
CRISPR	B:C3658200
-	O
mediated	O
deletion	O
of	O
Jak1	O
or	O
STAT3	O
,	O
or	O
by	O
administration	O
of	O
a	O
Jak	O
family	I:C0597721
inhibitor	O
.	O

The	O
tumorigenic	O
potential	O
of	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
was	O
attenuated	O
significantly	O
by	O
CRISPR	O
-	O
mediated	O
deletion	B:C0017260
of	O
Jak1	O
or	O
STAT3	O
,	O
or	O
by	O
administration	O
of	O
a	O
Jak	O
family	I:C0597721
inhibitor	O
.	O

The	O
tumorigenic	O
potential	O
of	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
was	O
attenuated	O
significantly	O
by	O
CRISPR	O
-	O
mediated	O
deletion	O
of	O
Jak1	B:C1334290
or	O
STAT3	O
,	O
or	O
by	O
administration	O
of	O
a	O
Jak	O
family	I:C0597721
inhibitor	O
.	O

The	O
tumorigenic	O
potential	O
of	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
was	O
attenuated	O
significantly	O
by	O
CRISPR	O
-	O
mediated	O
deletion	O
of	O
Jak1	O
or	O
STAT3	B:C1367307
,	O
or	O
by	O
administration	O
of	O
a	O
Jak	O
family	I:C0597721
inhibitor	O
.	O

The	O
tumorigenic	O
potential	O
of	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
was	O
attenuated	O
significantly	O
by	O
CRISPR	O
-	O
mediated	O
deletion	O
of	O
Jak1	O
or	O
STAT3	O
,	O
or	O
by	O
administration	O
of	O
a	O
Jak	B:C0597721
family	I:C0597721
inhibitor	O
.	O

Analysis	B:C0936012
of	O
primary	O
clinical	O
samples	O
of	O
nodular	O
fasciitis	I:C0410005
confirmed	O
the	O
activation	O
of	O
a	O
Jak1	O
-	O
STAT3	O
gene	O
signature	O
in	O
vivo	O
Together	O
,	O
our	O
studies	O
highlight	O
Jak1	O
as	O
the	O
first	O
identified	O
substrate	O
for	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
,	O
and	O
they	O
offer	O
a	O
mechanistic	O
rationale	O
for	O
the	O
clinical	O
investigation	I:C1261322
of	O
Jak	O
and	O
STAT3	O
inhibitors	O
as	O
therapeutics	O
for	O
the	O
treatment	O
of	O
bone	O
and	O
soft	O
tissue	I:C0037579
tumors	I:C0037579
along	O
with	O
other	O
neoplasms	O
driven	O
by	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
overexpression	O
.	O

Analysis	O
of	O
primary	O
clinical	O
samples	O
of	O
nodular	B:C0410005
fasciitis	I:C0410005
confirmed	O
the	O
activation	O
of	O
a	O
Jak1	O
-	O
STAT3	O
gene	O
signature	O
in	O
vivo	O
Together	O
,	O
our	O
studies	O
highlight	O
Jak1	O
as	O
the	O
first	O
identified	O
substrate	O
for	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
,	O
and	O
they	O
offer	O
a	O
mechanistic	O
rationale	O
for	O
the	O
clinical	O
investigation	I:C1261322
of	O
Jak	O
and	O
STAT3	O
inhibitors	O
as	O
therapeutics	O
for	O
the	O
treatment	O
of	O
bone	O
and	O
soft	O
tissue	I:C0037579
tumors	I:C0037579
along	O
with	O
other	O
neoplasms	O
driven	O
by	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
overexpression	O
.	O

Analysis	O
of	O
primary	O
clinical	O
samples	O
of	O
nodular	O
fasciitis	I:C0410005
confirmed	B:C0750484
the	O
activation	O
of	O
a	O
Jak1	O
-	O
STAT3	O
gene	O
signature	O
in	O
vivo	O
Together	O
,	O
our	O
studies	O
highlight	O
Jak1	O
as	O
the	O
first	O
identified	O
substrate	O
for	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
,	O
and	O
they	O
offer	O
a	O
mechanistic	O
rationale	O
for	O
the	O
clinical	O
investigation	I:C1261322
of	O
Jak	O
and	O
STAT3	O
inhibitors	O
as	O
therapeutics	O
for	O
the	O
treatment	O
of	O
bone	O
and	O
soft	O
tissue	I:C0037579
tumors	I:C0037579
along	O
with	O
other	O
neoplasms	O
driven	O
by	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
overexpression	O
.	O

Analysis	O
of	O
primary	O
clinical	O
samples	O
of	O
nodular	O
fasciitis	I:C0410005
confirmed	O
the	O
activation	O
of	O
a	O
Jak1	B:C0169658
-	O
STAT3	O
gene	O
signature	O
in	O
vivo	O
Together	O
,	O
our	O
studies	O
highlight	O
Jak1	O
as	O
the	O
first	O
identified	O
substrate	O
for	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
,	O
and	O
they	O
offer	O
a	O
mechanistic	O
rationale	O
for	O
the	O
clinical	O
investigation	I:C1261322
of	O
Jak	O
and	O
STAT3	O
inhibitors	O
as	O
therapeutics	O
for	O
the	O
treatment	O
of	O
bone	O
and	O
soft	O
tissue	I:C0037579
tumors	I:C0037579
along	O
with	O
other	O
neoplasms	O
driven	O
by	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
overexpression	O
.	O

Analysis	O
of	O
primary	O
clinical	O
samples	O
of	O
nodular	O
fasciitis	I:C0410005
confirmed	O
the	O
activation	O
of	O
a	O
Jak1	O
-	O
STAT3	B:C0253050
gene	O
signature	O
in	O
vivo	O
Together	O
,	O
our	O
studies	O
highlight	O
Jak1	O
as	O
the	O
first	O
identified	O
substrate	O
for	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
,	O
and	O
they	O
offer	O
a	O
mechanistic	O
rationale	O
for	O
the	O
clinical	O
investigation	I:C1261322
of	O
Jak	O
and	O
STAT3	O
inhibitors	O
as	O
therapeutics	O
for	O
the	O
treatment	O
of	O
bone	O
and	O
soft	O
tissue	I:C0037579
tumors	I:C0037579
along	O
with	O
other	O
neoplasms	O
driven	O
by	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
overexpression	O
.	O

Analysis	O
of	O
primary	O
clinical	O
samples	O
of	O
nodular	O
fasciitis	I:C0410005
confirmed	O
the	O
activation	O
of	O
a	O
Jak1	O
-	O
STAT3	O
gene	O
signature	O
in	O
vivo	O
Together	O
,	O
our	O
studies	B:C0947630
highlight	O
Jak1	O
as	O
the	O
first	O
identified	O
substrate	O
for	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
,	O
and	O
they	O
offer	O
a	O
mechanistic	O
rationale	O
for	O
the	O
clinical	O
investigation	I:C1261322
of	O
Jak	O
and	O
STAT3	O
inhibitors	O
as	O
therapeutics	O
for	O
the	O
treatment	O
of	O
bone	O
and	O
soft	O
tissue	I:C0037579
tumors	I:C0037579
along	O
with	O
other	O
neoplasms	O
driven	O
by	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
overexpression	O
.	O

Analysis	O
of	O
primary	O
clinical	O
samples	O
of	O
nodular	O
fasciitis	I:C0410005
confirmed	O
the	O
activation	O
of	O
a	O
Jak1	O
-	O
STAT3	O
gene	O
signature	O
in	O
vivo	O
Together	O
,	O
our	O
studies	O
highlight	O
Jak1	B:C0169658
as	O
the	O
first	O
identified	O
substrate	O
for	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
,	O
and	O
they	O
offer	O
a	O
mechanistic	O
rationale	O
for	O
the	O
clinical	O
investigation	I:C1261322
of	O
Jak	O
and	O
STAT3	O
inhibitors	O
as	O
therapeutics	O
for	O
the	O
treatment	O
of	O
bone	O
and	O
soft	O
tissue	I:C0037579
tumors	I:C0037579
along	O
with	O
other	O
neoplasms	O
driven	O
by	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
overexpression	O
.	O

Analysis	O
of	O
primary	O
clinical	O
samples	O
of	O
nodular	O
fasciitis	I:C0410005
confirmed	O
the	O
activation	O
of	O
a	O
Jak1	O
-	O
STAT3	O
gene	O
signature	O
in	O
vivo	O
Together	O
,	O
our	O
studies	O
highlight	O
Jak1	O
as	O
the	O
first	O
identified	O
substrate	O
for	O
ubiquitin	B:C1175888
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
,	O
and	O
they	O
offer	O
a	O
mechanistic	O
rationale	O
for	O
the	O
clinical	O
investigation	I:C1261322
of	O
Jak	O
and	O
STAT3	O
inhibitors	O
as	O
therapeutics	O
for	O
the	O
treatment	O
of	O
bone	O
and	O
soft	O
tissue	I:C0037579
tumors	I:C0037579
along	O
with	O
other	O
neoplasms	O
driven	O
by	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
overexpression	O
.	O

Analysis	O
of	O
primary	O
clinical	O
samples	O
of	O
nodular	O
fasciitis	I:C0410005
confirmed	O
the	O
activation	O
of	O
a	O
Jak1	O
-	O
STAT3	O
gene	O
signature	O
in	O
vivo	O
Together	O
,	O
our	O
studies	O
highlight	O
Jak1	O
as	O
the	O
first	O
identified	O
substrate	O
for	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
,	O
and	O
they	O
offer	O
a	O
mechanistic	O
rationale	O
for	O
the	O
clinical	B:C1261322
investigation	I:C1261322
of	O
Jak	O
and	O
STAT3	O
inhibitors	O
as	O
therapeutics	O
for	O
the	O
treatment	O
of	O
bone	O
and	O
soft	O
tissue	I:C0037579
tumors	I:C0037579
along	O
with	O
other	O
neoplasms	O
driven	O
by	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
overexpression	O
.	O

Analysis	O
of	O
primary	O
clinical	O
samples	O
of	O
nodular	O
fasciitis	I:C0410005
confirmed	O
the	O
activation	O
of	O
a	O
Jak1	O
-	O
STAT3	O
gene	O
signature	O
in	O
vivo	O
Together	O
,	O
our	O
studies	O
highlight	O
Jak1	O
as	O
the	O
first	O
identified	O
substrate	O
for	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
,	O
and	O
they	O
offer	O
a	O
mechanistic	O
rationale	O
for	O
the	O
clinical	O
investigation	I:C1261322
of	O
Jak	B:C0597721
and	O
STAT3	O
inhibitors	O
as	O
therapeutics	O
for	O
the	O
treatment	O
of	O
bone	O
and	O
soft	O
tissue	I:C0037579
tumors	I:C0037579
along	O
with	O
other	O
neoplasms	O
driven	O
by	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
overexpression	O
.	O

Analysis	O
of	O
primary	O
clinical	O
samples	O
of	O
nodular	O
fasciitis	I:C0410005
confirmed	O
the	O
activation	O
of	O
a	O
Jak1	O
-	O
STAT3	O
gene	O
signature	O
in	O
vivo	O
Together	O
,	O
our	O
studies	O
highlight	O
Jak1	O
as	O
the	O
first	O
identified	O
substrate	O
for	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
,	O
and	O
they	O
offer	O
a	O
mechanistic	O
rationale	O
for	O
the	O
clinical	O
investigation	I:C1261322
of	O
Jak	O
and	O
STAT3	B:C0253050
inhibitors	O
as	O
therapeutics	O
for	O
the	O
treatment	O
of	O
bone	O
and	O
soft	O
tissue	I:C0037579
tumors	I:C0037579
along	O
with	O
other	O
neoplasms	O
driven	O
by	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
overexpression	O
.	O

Analysis	O
of	O
primary	O
clinical	O
samples	O
of	O
nodular	O
fasciitis	I:C0410005
confirmed	O
the	O
activation	O
of	O
a	O
Jak1	O
-	O
STAT3	O
gene	O
signature	O
in	O
vivo	O
Together	O
,	O
our	O
studies	O
highlight	O
Jak1	O
as	O
the	O
first	O
identified	O
substrate	O
for	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
,	O
and	O
they	O
offer	O
a	O
mechanistic	O
rationale	O
for	O
the	O
clinical	O
investigation	I:C1261322
of	O
Jak	O
and	O
STAT3	O
inhibitors	O
as	O
therapeutics	O
for	O
the	O
treatment	B:C0087111
of	O
bone	O
and	O
soft	O
tissue	I:C0037579
tumors	I:C0037579
along	O
with	O
other	O
neoplasms	O
driven	O
by	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
overexpression	O
.	O

Analysis	O
of	O
primary	O
clinical	O
samples	O
of	O
nodular	O
fasciitis	I:C0410005
confirmed	O
the	O
activation	O
of	O
a	O
Jak1	O
-	O
STAT3	O
gene	O
signature	O
in	O
vivo	O
Together	O
,	O
our	O
studies	O
highlight	O
Jak1	O
as	O
the	O
first	O
identified	O
substrate	O
for	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
,	O
and	O
they	O
offer	O
a	O
mechanistic	O
rationale	O
for	O
the	O
clinical	O
investigation	I:C1261322
of	O
Jak	O
and	O
STAT3	O
inhibitors	O
as	O
therapeutics	O
for	O
the	O
treatment	O
of	O
bone	B:C0005967
and	O
soft	O
tissue	I:C0037579
tumors	I:C0037579
along	O
with	O
other	O
neoplasms	O
driven	O
by	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
overexpression	O
.	O

Analysis	O
of	O
primary	O
clinical	O
samples	O
of	O
nodular	O
fasciitis	I:C0410005
confirmed	O
the	O
activation	O
of	O
a	O
Jak1	O
-	O
STAT3	O
gene	O
signature	O
in	O
vivo	O
Together	O
,	O
our	O
studies	O
highlight	O
Jak1	O
as	O
the	O
first	O
identified	O
substrate	O
for	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
,	O
and	O
they	O
offer	O
a	O
mechanistic	O
rationale	O
for	O
the	O
clinical	O
investigation	I:C1261322
of	O
Jak	O
and	O
STAT3	O
inhibitors	O
as	O
therapeutics	O
for	O
the	O
treatment	O
of	O
bone	O
and	O
soft	B:C0037579
tissue	I:C0037579
tumors	I:C0037579
along	O
with	O
other	O
neoplasms	O
driven	O
by	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
overexpression	O
.	O

Analysis	O
of	O
primary	O
clinical	O
samples	O
of	O
nodular	O
fasciitis	I:C0410005
confirmed	O
the	O
activation	O
of	O
a	O
Jak1	O
-	O
STAT3	O
gene	O
signature	O
in	O
vivo	O
Together	O
,	O
our	O
studies	O
highlight	O
Jak1	O
as	O
the	O
first	O
identified	O
substrate	O
for	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
,	O
and	O
they	O
offer	O
a	O
mechanistic	O
rationale	O
for	O
the	O
clinical	O
investigation	I:C1261322
of	O
Jak	O
and	O
STAT3	O
inhibitors	O
as	O
therapeutics	O
for	O
the	O
treatment	O
of	O
bone	O
and	O
soft	O
tissue	I:C0037579
tumors	I:C0037579
along	O
with	O
other	O
neoplasms	B:C0027651
driven	O
by	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
overexpression	O
.	O

Analysis	O
of	O
primary	O
clinical	O
samples	O
of	O
nodular	O
fasciitis	I:C0410005
confirmed	O
the	O
activation	O
of	O
a	O
Jak1	O
-	O
STAT3	O
gene	O
signature	O
in	O
vivo	O
Together	O
,	O
our	O
studies	O
highlight	O
Jak1	O
as	O
the	O
first	O
identified	O
substrate	O
for	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
,	O
and	O
they	O
offer	O
a	O
mechanistic	O
rationale	O
for	O
the	O
clinical	O
investigation	I:C1261322
of	O
Jak	O
and	O
STAT3	O
inhibitors	O
as	O
therapeutics	O
for	O
the	O
treatment	O
of	O
bone	O
and	O
soft	O
tissue	I:C0037579
tumors	I:C0037579
along	O
with	O
other	O
neoplasms	O
driven	O
by	O
ubiquitin	B:C1175888
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
overexpression	O
.	O

Analysis	O
of	O
primary	O
clinical	O
samples	O
of	O
nodular	O
fasciitis	I:C0410005
confirmed	O
the	O
activation	O
of	O
a	O
Jak1	O
-	O
STAT3	O
gene	O
signature	O
in	O
vivo	O
Together	O
,	O
our	O
studies	O
highlight	O
Jak1	O
as	O
the	O
first	O
identified	O
substrate	O
for	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
,	O
and	O
they	O
offer	O
a	O
mechanistic	O
rationale	O
for	O
the	O
clinical	O
investigation	I:C1261322
of	O
Jak	O
and	O
STAT3	O
inhibitors	O
as	O
therapeutics	O
for	O
the	O
treatment	O
of	O
bone	O
and	O
soft	O
tissue	I:C0037579
tumors	I:C0037579
along	O
with	O
other	O
neoplasms	O
driven	O
by	O
ubiquitin	O
-	I:C1175888
specific	I:C1175888
protease	I:C1175888
6	I:C1175888
overexpression	B:C1514559
.	O

